The first American investigation of Medicare coverage of biologic disease modifying drugs (DMARDs) found that in starting a single biologic DMARD, patients face more than $2,700 in copayments each year before receiving relief from catastrophic coverage. - Source
Patients grapple with high cost of arthritis medications
No comments:
Post a Comment